One of the most common conditions on applications, and one of the least consequential when it is mild and controlled.
Last reviewed September 2026 by Dev Gaymes, Licensed Insurance Advisor · Editorial policy
Asthma is on a large share of applications and it surprises people how little it usually matters. Mild, well-controlled asthma frequently reaches Preferred - the same class as someone with no respiratory history. What moves the file is severity, and severity is measured by specific things rather than by the diagnosis itself.
The diagnosis tells an underwriter almost nothing. These are the questions that decide the outcome:
General industry patterns, not promises. Individual outcomes depend on your full profile and the carrier's guidelines when you apply.
As with several conditions, what you take tells the underwriter how significant the condition is:
General descriptions of how treatment classes are commonly assessed. Not medical advice and not a reason to change any prescription.
Three situations change the picture materially:
Yes, and usually at better rates than people expect. Asthma is one of the most commonly disclosed conditions and mild, well-controlled cases frequently qualify for Preferred - the same class available to someone with no respiratory history. What matters is severity, treatment intensity and whether you have had hospitalizations, not the diagnosis itself.
A rescue inhaler used occasionally generally has minimal impact and often none at all. Daily controller therapy indicates persistent asthma and is usually still well tolerated in underwriting, commonly Standard or better when stable. The medication that changes outcomes most is frequent or maintenance oral steroid use, which suggests poorly controlled disease. Never adjust asthma medication for an application - it is medically unsafe and prescription databases show your history regardless.
Usually not, in any meaningful way. If you have had no symptoms, no medication and no treatment as an adult, most carriers treat childhood asthma as history rather than a current condition, and it frequently has no rating impact. Disclose it anyway, since it may appear in older medical records, but do not expect it to cost you anything.
Three things primarily. Recent hospitalizations or emergency visits, particularly within the last one to two years, are the most common reason an otherwise mild file gets rated. Current tobacco use alongside asthma is assessed far more cautiously than either factor alone. And any suggestion of COPD or asthma-COPD overlap in your records moves the file into different and more conservative territory.
Considerably, and in both directions at once. Tobacco use puts you in tobacco rate classes, which are typically two to three times non-tobacco rates at every level. It also makes the asthma itself a more serious file, because the combination carries greater respiratory risk than either alone. Vaping counts, and nicotine is verified through lab testing rather than relying on disclosure.
Not usually. Most asthma applications are assessed from your medical records, medication history and the application questions. If you have had recent pulmonary function testing, providing the results can strengthen a case by giving the underwriter objective evidence of good lung function. Where asthma is severe or the records are unclear, an underwriter may request testing before making an offer.
Generally yes, though the rate class narrows and carrier selection matters more. Severe persistent asthma, particularly with oral steroid dependence or biologic therapy, is typically table rated rather than declined. Stable long-term control on a biologic can actually support the case, because it demonstrates the condition is being managed with modern treatment rather than progressing unchecked.
Yes, always. Every inhaler prescription appears in the databases carriers check, and omitting a condition creates a misstatement that can allow a carrier to contest a claim during the two-year contestability period. Since mild controlled asthma frequently carries little or no rating impact, there is very little to gain by leaving it off and a great deal to lose.
Dev Gaymes is a licensed insurance broker, not a physician. General education, not medical advice and not advice about your situation, and not an offer of insurance or a quote. Never change, start or stop any medication, diet or treatment plan for an insurance application or for any reason other than your physician’s direction. Underwriting guidelines - including build charts, thresholds and rate classes - vary by carrier, product and state, change over time, and are applied case by case at the underwriter’s discretion. Nothing here describes any particular insurer’s current guidelines or predicts your outcome. All coverage is subject to carrier underwriting approval, and policy terms, benefits, exclusions and limitations are governed solely by the issued policy contract. Always answer every application question completely and truthfully.
We’ll tell you where you’re likely to land before you apply anywhere.
Prefer to talk now? Call 214-989-7704